Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study

SIMPLE SUMMARY: Collecting duct carcinoma (CDC) and renal medullary carcinoma (RMC) are two rare cancers with a very poor prognosis. Currently, first-line treatment is a platinum-based doublet, but very few studies have evaluated the effectiveness of treatments for subsequent lines. Additionally, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillaume, Zoé, Colomba, Emeline, Thouvenin, Jonathan, Saldana, Carolina, Campedel, Luca, Dumont, Clément, Laguerre, Brigitte, Maillet, Denis, Vicier, Cécile, Rolland, Frédéric, Borchiellini, Delphine, Barthelemy, Philippe, Albiges, Laurence, Auclin, Edouard, Roulleaux Dugage, Matthieu, Oudard, Stéphane, Thibault, Constance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996870/
https://www.ncbi.nlm.nih.gov/pubmed/35406448
http://dx.doi.org/10.3390/cancers14071678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996870/
https://www.ncbi.nlm.nih.gov/pubmed/35406448
http://dx.doi.org/10.3390/cancers14071678

Ejemplares similares